Jefferson Petto, Pedro Elias Santos Souza, Francisco Tiago Oliveira de Oliveira, Pedro Henrique Silva Santos
{"title":"Inspiratory muscle training in quality of life and functional capacity in cardiotoxicity: case report","authors":"Jefferson Petto, Pedro Elias Santos Souza, Francisco Tiago Oliveira de Oliveira, Pedro Henrique Silva Santos","doi":"10.1590/1809-2950/22008229032022en","DOIUrl":null,"url":null,"abstract":"ABSTRACT Cancer patients develop frequent cardiac problems due to chemotherapy toxicity, which impacts functional capacity (FC) and quality of life (QoL). Inspiratory Muscle Training (IMT) may be a viable therapeutic resource since cause-effect studies have shown improvement in FC and QoL in other populations. However, its effect was not evaluated in cardio-oncology patients. The study aimed to describe the effect of an IMT program on the FC and QoL of a patient with cardiotoxicity, LDM, aged 41 years, female and, sedentary that developed heart failure after chemotherapy. The QoL was evaluated by the Minnesota test. Dynamic Inspiratory Muscle Strength (S-Index) and Glycemic Threshold (GT) of the inspiratory muscles were also evaluated. The GT was determined by capillary glycemia with a digital glucometer (Accu-Chek - Roche), at the lowest value of glycemia of the load corresponding to the Incremental Inspiratory Muscle Test (IIMT). The load progression was performed every two weeks. After two months, all tests were reapplied. In the Minnesota test, the values related to FC, pre and post IMT, were 36 v. 8 (78% improvement); the clinical and psychological aspects 32 v. 7 (78% improvement); S-Index was 41 v. 51cmH2O (24% improvement). IMT improved the FC and QoL of a cardio-oncology patient, configuring itself as a possible and viable therapeutic resource for this population.","PeriodicalId":436434,"journal":{"name":"Fisioterapia e Pesquisa","volume":"26 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fisioterapia e Pesquisa","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1590/1809-2950/22008229032022en","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
ABSTRACT Cancer patients develop frequent cardiac problems due to chemotherapy toxicity, which impacts functional capacity (FC) and quality of life (QoL). Inspiratory Muscle Training (IMT) may be a viable therapeutic resource since cause-effect studies have shown improvement in FC and QoL in other populations. However, its effect was not evaluated in cardio-oncology patients. The study aimed to describe the effect of an IMT program on the FC and QoL of a patient with cardiotoxicity, LDM, aged 41 years, female and, sedentary that developed heart failure after chemotherapy. The QoL was evaluated by the Minnesota test. Dynamic Inspiratory Muscle Strength (S-Index) and Glycemic Threshold (GT) of the inspiratory muscles were also evaluated. The GT was determined by capillary glycemia with a digital glucometer (Accu-Chek - Roche), at the lowest value of glycemia of the load corresponding to the Incremental Inspiratory Muscle Test (IIMT). The load progression was performed every two weeks. After two months, all tests were reapplied. In the Minnesota test, the values related to FC, pre and post IMT, were 36 v. 8 (78% improvement); the clinical and psychological aspects 32 v. 7 (78% improvement); S-Index was 41 v. 51cmH2O (24% improvement). IMT improved the FC and QoL of a cardio-oncology patient, configuring itself as a possible and viable therapeutic resource for this population.
癌症患者由于化疗毒性而频繁出现心脏问题,影响功能容量(FC)和生活质量(QoL)。吸气肌训练(IMT)可能是一种可行的治疗资源,因为因果研究表明其他人群的FC和QoL有所改善。然而,其在心脏肿瘤患者中的效果尚未评估。该研究旨在描述IMT方案对心脏毒性、LDM患者的FC和QoL的影响,该患者年龄41岁,女性,久坐,化疗后发生心力衰竭。生活质量采用明尼苏达测验评估。动态吸气肌力量(S-Index)和血糖阈值(GT)也进行了评估。GT采用数字血糖仪(Accu-Chek - Roche)测定毛细血管血糖,与增量吸气肌试验(IIMT)对应的负荷最低血糖值。每两周进行一次负荷进展。两个月后,再次进行所有测试。在明尼苏达测试中,IMT前后的FC值分别为36 vs . 8(改善78%);临床和心理方面32 vs . 7(改善78%);S-Index为41 vs . 51cmH2O(改善24%)。IMT改善了心脏肿瘤患者的FC和QoL,使其成为这一人群可能和可行的治疗资源。